BICO Group AB (publ) (OM: BICO)
Health Care · Life Sciences Tools & Services · SE
Skr23.90
+0.84% today · +9.1% 1Y
BICO Group AB (publ) (OM: BICO) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $167.28M and employs 554 people.
Over the last twelve months the share price has gained 9.1%, trading between 12.94 and 25.42.
Tweenvest scores BICO Group AB (publ) across four factors: quality 46/100, value 58/100, growth 0/100. Its strongest factor is value.
BICO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $167.28M
- Revenue (TTM)
- $155.20M
- P/E
- —
- EPS
- -11.89
- Dividend yield
- —
- Beta (5Y)
- 2.56
- 52-week high
- Skr25.42
- 52-week low
- Skr12.94
- Avg volume (3M)
- —
- Shares outstanding
- 70.57M
- Employees
- 554
- Next earnings
- —
About BICO Group AB (publ)
BICO Group AB (publ) is a global bio-convergence enterprise, extending its operations across North America, Europe, Asia, and other international markets. Its business is segmented into two primary divisions: Laboratory Solutions and Bioautomation. The Laboratory Solutions division equips researchers with advanced tools like 3D bioprinters, hybrid microscopes, and instruments for single-cell dispensing and liquid handling. It also supplies essential consumables such as bioinks, reagents, microscope lenses, and specialized software, alongside 3D reconstructed human tissues crucial for regulatory testing. Furthermore, this segment provides specialized services in 3D cell culture, tissue imaging, multiplex imaging, and digital pathology, primarily benefiting pharmaceutical and biotechnology firms. Conversely, the Bioautomation segment caters to industrial clients with precision dispensing and biosensor technologies, while also delivering diagnostic automation and sophisticated robotics solutions to the medical and diagnostics sectors. Beyond these segments, BICO Group's comprehensive portfolio includes solutions for tissue engineering, multi-omics, cell line development, and diagnostics, contributing to a robust industrial ecosystem. Its principal clientele spans the medical, pharmaceutical, and cosmetic industries. Originally established in 2016 as Cellink AB (publ), the company adopted its current name, BICO Group AB (publ), in August 2021. Its headquarters are located in Gothenburg, Sweden.
- ISIN
- SE0013647385
- Founded
- 2016
- Listed since
- Nov 3, 2016
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Diaceutics PLCAIM: DXRX | $228.03M | £2.03 | -0.25% |
| Windlas Biotech LimitedNSEI: WINDLAS | $202.39M | Rs949.20 | -12.31% |
| Tarsons Products LimitedNSEI: TARSONS | $176.45M | Rs320.95 | -2.57% |
| Fine Foods & Pharmaceuticals N.T.M. S.p.A.BIT: FF | $168.81M | €6.62 | -1.19% |
| Vitrafy Life Sciences LimitedASX: VFY | $165.37M | AU$3.11 | -12.64% |
| BLS Pharmaceuticals LimitedASX: BLS | $163.93M | AU$1.02 | -0.97% |
| Quanterix CorporationNasdaqGM: QTRX | $155.12M | $3.08 | -6.10% |
| Codexis, Inc.NasdaqGS: CDXS | $154.40M | $1.33 | -6.03% |
Figures last refreshed Oct 11, 2026.